Successful vemurafenib salvage treatment in a patient with primary refractory hairy cell leukemia and pulmonary aspergillosis
暂无分享,去创建一个
M. Lübbert | J. Duyster | T. Wengenmayer | R. Zeiser | P. Haas | H. Maurer
[1] R. Kurzrock,et al. Rapid response to vemurafenib in a heavily pretreated patient with hairy cell leukemia and a BRAF mutation. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Till Acker,et al. Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] G. Follows,et al. Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib , 2013, British journal of haematology.
[4] R. Ballotti,et al. Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation , 2013, Haematologica.
[5] A. Hauschild,et al. Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective BRAF inhibition. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] C. von Kalle,et al. BRAF inhibition in refractory hairy-cell leukemia. , 2012, The New England journal of medicine.
[7] S. Pileri,et al. BRAF mutations in hairy-cell leukemia. , 2011, The New England journal of medicine.
[8] C. Robert,et al. RAF inhibition and induction of cutaneous squamous cell carcinoma , 2011, Current opinion in oncology.
[9] A. Tefferi,et al. BRAF mutations in hairy-cell leukemia. , 2011, The New England journal of medicine.